Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.07K Buy
42
+19
+83% +$3.63K ﹤0.01% 717
2026
Q1
$4.22K Sell
23
-10
-30% -$1.84K ﹤0.01% 780
2025
Q4
$5.81K Buy
33
+6
+22% +$980 ﹤0.01% 775
2025
Q3
$3.78K Sell
27
-68
-72% -$9.19K ﹤0.01% 803
2025
Q2
$11.9K Buy
95
+23
+32% +$2.87K ﹤0.01% 747
2025
Q1
$9.85K Buy
+72
New +$10.3K ﹤0.01% 838
2023
Q3
Sell
-45
Closed -$12.8K 637
2023
Q2
$12.8K Hold
45
﹤0.01% 452
2023
Q1
$12.5K Hold
45
﹤0.01% 489
2022
Q4
$12.5K Buy
45
+7
+18% +$1.98K ﹤0.01% 533
2022
Q3
$10K Hold
38
﹤0.01% 539
2022
Q2
$8K Hold
38
﹤0.01% 597
2022
Q1
$8K Sell
38
-14
-27% -$3.04K ﹤0.01% 609
2021
Q4
$12K Hold
52
﹤0.01% 543
2021
Q3
$15K Sell
52
-40
-43% -$13.1K ﹤0.01% 455
2021
Q2
$32K Buy
+92
New +$27.9K ﹤0.01% 304
2018
Q1
Sell
-918
Closed -$292K 255
2017
Q4
$292K Sell
918
-367
-29% -$118K 0.03% 256
2017
Q3
$403 Sell
1,285
-120
-9% -$35.5K 0.05% 187
2017
Q2
$382K Sell
1,405
-65
-4% -$17.2K 0.05% 191
2017
Q1
$403K Buy
+1,470
New +$416K 0.05% 186

Other funds holding BIIB

SouthState Corp's BIIB Position: Q2 2026 in Review

SouthState Corp increased its Biogen (BIIB) stake by 83% in Q2 2026, buying an estimated $3.63K and bringing the position to 42 shares worth $9.07K. The position accounts for ﹤0.01% of the portfolio, ranked #717.

SouthState Corp first reported a position in BIIB in Q1 2017 and has held it in 19 quarters since. The position peaked at $403K in Q1 2017. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • SouthState Corp held 42 shares of Biogen worth $9.07K as of Q2 2026.
  • SouthState Corp bought 19 Biogen shares in Q2 2026, an estimated $3.63K.
  • Biogen made up ﹤0.01% of SouthState Corp's portfolio in Q2 2026, its #717 holding.
  • SouthState Corp first reported a position in Biogen in Q1 2017 and has held it in 19 quarters since.
  • SouthState Corp's Biogen position peaked at $403K in Q1 2017.
  • 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on SouthState Corp's 13F filing for Q2 2026, filed 6 Aug 2026.